Radnet stock analysis
Radnet (PQIA) Stock Price & Analysis
PQIA Stock Chart & Stats
- Day’s Range
- EUR 69.02 - EUR 69.02
- 52-Week Range
- EUR 43.85 - EUR 72.50
- Previous Close
- EUR 68.26
- Volume
- N/A
- Average Volume (3M)
- 4
- Market Cap
- EUR 5.37B
- Enterprise Value
- EUR 7.20B
- Total Cash (Recent Filing)
- EUR 750.61M
- Total Debt (Recent Filing)
- EUR 2.17B
- Price to Earnings (P/E)
- ―
- Beta
- 0.43
- Next Earnings
- Mar 02, 2027 (Est.)
- EPS Estimate
- 0.24
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Operating Growth
Record revenue and adjusted EBITDA, alongside higher guidance, indicate that RadNet is converting capacity expansion, advanced-imaging mix and operational improvements into scalable growth. This supports stronger reinvestment capacity and suggests the core imaging platform can compound over the next several quarters.
Digital Health And AI Expansion
Rapid ARR growth, a rising external customer mix and more than 3,000 accounts show that RadNet is building a broader technology platform beyond imaging centers. Increasing adoption of AI and informatics can deepen customer relationships and create a more recurring revenue base.
Liquidity And Cash Access
Substantial cash and undrawn revolver capacity provide financial flexibility to fund centers, technology deployment and strategic initiatives while managing operating volatility. Strong liquidity also improves RadNet's ability to pursue growth opportunities and meet obligations over the medium term.
Bears Say
Elevated Leverage
Meaningful leverage reduces financial flexibility and leaves more operating cash committed to debt service and refinancing needs. Because current losses make deleveraging harder, RadNet may have less capacity to absorb setbacks or fund expansion internally if earnings recovery slows.
Negative Free Cash Flow And Net Losses
Negative free cash flow after investment indicates that operating cash generation is not currently covering capital and working-capital demands. Combined with net losses, this can constrain debt reduction, increase reliance on financing and make the business more sensitive to execution or spending pressures.
Medicare Reimbursement Pressure
The finalized Medicare reduction creates a structural reimbursement headwind for a material portion of RadNet's business. Lower payment rates can pressure revenue and margins across affected procedures, requiring sustained volume growth, mix improvement or cost discipline to offset the impact.
Radnet News
PQIA FAQ
What was Radnet’s price range in the past 12 months?
What is Radnet’s market cap?
When is Radnet’s upcoming earnings report date?
How were Radnet’s earnings last quarter?
Is Radnet overvalued?
Does Radnet pay dividends?
What is Radnet’s EPS estimate?
How many shares outstanding does Radnet have?
What happened to Radnet’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Radnet?
What is the TipRanks Smart Score and how is it calculated?
Radnet Stock Smart Score
Company Description
Radnet
RadNet, Inc. operates as a prominent healthcare services company specializing in outpatient diagnostic imaging across the United States. Their comprehensive offerings span a broad spectrum of advanced imaging techniques, including magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, and general diagnostic radiology, along with various specialized procedures. Beyond direct patient services, the company also plays a significant role in developing and marketing specialized computerized systems for the diagnostic imaging sector, such as picture archiving communication systems (PACS) and associated support. Furthermore, RadNet is at the forefront of integrating artificial intelligence (AI) solutions, designing and deploying AI suites to augment radiologist interpretation, particularly in mammography, and extending these AI capabilities to lung and prostate cancer diagnostics. As of December 31, 2021, its operational footprint included ownership and management of 347 centers situated across seven states: Arizona, California, Delaware, Florida, Maryland, New Jersey, and New York. Established in 1981, the company maintains its headquarters in Los Angeles, California.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Howard G. Berger
- Employees
- 9,060
- Website
- www.radnet.com
- Address
- 1508, 1510 and 1516 Cotner Avenue, Los Angeles, CA, 90025, US
Radnet (PQIA) Earnings & Revenues
PQIA Earnings Call
Earnings Call SentimentPositive
The call was strongly positive. RadNet reported record company revenue and adjusted EBITDA, broad-based imaging volume growth, expanding advanced-imaging mix, raised Imaging Center and Digital Health guidance, strong liquidity, substantial Digital Health bookings and ARR growth, and continued progress in AI deployment and the planned ONRAD acquisition. The main challenges were year-over-year Digital Health EBITDA and margin declines, labor shortages, implementation seasonality and constraints, and expected 2027 Medicare reimbursement pressure, but management characterized the implementation constraints as resolved and remained confident about fourth-quarter and 2027 growth.
View all DE:PQIA earnings summariesPQIA Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 15 | 5 | 2 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 12 | 0 | 0 |










